GPCR · Structure Therapeutics Inc. · Held by Funds
Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this exact listed security, matched by CUSIP. Each row is one fund position with its size, value and weight in that fund.
Fund Ownership of GPCR by Fund Type
Registered funds' Form N-PORT reports for the quarter ended Jun 30, 2026Index funds and index ETFs hold 0.90% of shares outstanding.
| Fund type | Of shares outstanding | Shares |
|---|---|---|
| Index funds | 0.11% | 77,781 |
| Index ETFs | 0.79% | 564,170 |
| Active ETFs | 0.16% | 117,467 |
| Active funds | 20.44% | 14,572,859 |
| Unclassified | 0.70% | 495,902 |
| All registered funds | 22.20% | 15,828,179 |
How fund types are measured
Each fund series counts once, with its latest Form N-PORT report dated inside the quarter; only long share positions count, restated to today's split basis. The fund type is the series' latest Form N-CEN answer on or before the quarter end (the index-fund box and the exchange-traded flag), never its name. Unclassified funds have no usable N-CEN; unit investment trusts are among them, so index ownership is a floor. Funds sit inside their advisers' 13F reports, so these shares overlap the 13F figures and are never added to them.
Funds holding GPCR
150 fund positions| Fund | Ticker | Balance | Value | % of Fund | Side | Reported | Open |
|---|---|---|---|---|---|---|---|
| Heritage Fund | — | 967,353 | $46,471,638 | 0.87% | Long | 2026-07-31 | |
| Global Emerging Markets Fund | — | 625,751 | $30,061,078 | 0.40% | Long | 2026-07-31 | |
| Janus Henderson Global Life Sciences Fund | — | 549,353 | $29,483,776 | 0.51% | Long | 2026-06-30 | |
| Fidelity Advisor Growth Opportunities Fund | — | 733,500 | $28,855,890 | 0.08% | Long | 2026-05-31 | |
| Fidelity Advisor Biotechnology Fund | — | 527,900 | $25,360,316 | 1.15% | Long | 2026-07-31 | |
| Janus Henderson Triton Fund | — | 467,112 | $25,069,901 | 0.42% | Long | 2026-06-30 | |
| T. Rowe Price Health Sciences Fund, Inc. | — | 419,407 | $22,509,574 | 0.19% | Long | 2026-06-30 | |
| iShares Biotechnology ETF | IBB | 414,261 | $22,233,388 | 0.24% | Long | 2026-06-30 | |
| Select Biotechnology Portfolio | FBIOX | 542,038 | $21,323,775 | 0.40% | Long | 2026-05-31 | |
| Select Health Care Portfolio | — | 540,000 | $21,243,600 | 0.37% | Long | 2026-05-31 | |
| Fidelity Stock Selector Small Cap Fund | — | 433,100 | $20,806,124 | 0.28% | Long | 2026-07-31 | |
| Fidelity Small Cap Growth Fund | — | 414,389 | $19,907,248 | 0.23% | Long | 2026-07-31 | |
| Aggressive Growth Portfolio | — | 400,000 | $19,216,000 | 3.76% | Long | 2026-07-31 | |
| Permanent Portfolio | — | 400,000 | $19,216,000 | 0.27% | Long | 2026-07-31 | |
| abrdn Healthcare Investors | HQH | 301,239 | $16,167,497 | 1.19% | Long | 2026-06-30 | |
| Fidelity Contrafund | — | 300,525 | $16,129,177 | 0.01% | Long | 2026-06-30 | |
| SmallCap Fund | — | 287,100 | $13,792,284 | 0.66% | Long | 2026-07-31 | |
| Janus Henderson Venture Fund | — | 252,725 | $13,563,751 | 0.37% | Long | 2026-06-30 | |
| Focused Dynamic Growth Fund | — | 263,026 | $12,635,769 | 0.63% | Long | 2026-07-31 | |
| Fidelity Series Small Cap Opportunities Fund | FSOPX | 248,605 | $11,942,984 | 0.25% | Long | 2026-07-31 | |
| Fidelity Advisor New Insights Fund | — | 216,800 | $11,635,656 | 0.04% | Long | 2026-06-30 | |
| T. Rowe Price New Horizons Fund, Inc. | — | 207,816 | $11,153,485 | 0.08% | Long | 2026-06-30 | |
| Fidelity Advisor Health Care Fund | — | 228,000 | $10,953,120 | 0.35% | Long | 2026-07-31 | |
| Fidelity Fund | — | 197,200 | $10,583,724 | 0.12% | Long | 2026-06-30 | |
| Principal Capital Appreciation Fund | — | 211,327 | $10,152,149 | 0.26% | Long | 2026-07-31 | |
| Fidelity Small Cap Growth K6 Fund | FOCSX | 207,912 | $9,988,092 | 0.22% | Long | 2026-07-31 | |
| Fidelity Puritan Fund | — | 244,500 | $9,618,630 | 0.03% | Long | 2026-05-31 | |
| abrdn World Healthcare Fund | THW | 176,459 | $9,470,555 | 1.67% | Long | 2026-06-30 | |
| THE HARTFORD GROWTH OPPORTUNITIES FUND | — | 195,389 | $9,386,488 | 0.14% | Long | 2026-07-31 | |
| Fidelity Growth Company Fund | — | 230,777 | $9,078,767 | 0.01% | Long | 2026-05-31 | |
| abrdn Life Sciences Investors | HQL | 162,217 | $8,706,186 | 1.26% | Long | 2026-06-30 | |
| Bridge Builder Small/Mid Cap Growth Fund | BBGSX | 147,713 | $7,927,757 | 0.07% | Long | 2026-06-30 | |
| AB Small Cap Growth Portfolio | — | 142,364 | $7,640,676 | 0.24% | Long | 2026-06-30 | |
| AB DISCOVERY GROWTH FUND, INC. | — | 138,229 | $7,418,750 | 0.26% | Long | 2026-06-30 | |
| Driehaus Small Cap Growth Fund | — | 137,401 | $7,374,312 | 0.46% | Long | 2026-06-30 | |
| Strategic Advisers Fidelity U.S. Total Stock Fund | FCTDX | 183,200 | $7,207,088 | 0.00% | Long | 2026-05-31 | |
| VIP Contrafund Portfolio | — | 126,600 | $6,794,622 | 0.02% | Long | 2026-06-30 | |
| Mid Cap Growth Fund | — | 124,970 | $6,707,140 | 0.50% | Long | 2026-06-30 | |
| Fidelity Series Opportunistic Insights Fund | FVWSX | 117,800 | $6,322,326 | 0.04% | Long | 2026-06-30 | |
| Franklin Small Cap Growth Fund | — | 128,923 | $6,193,461 | 0.25% | Long | 2026-07-31 | |
| VIP Growth Opportunities Portfolio | — | 102,200 | $5,485,074 | 0.10% | Long | 2026-06-30 | |
| Fidelity U.S. Equity Central Fund | — | 100,000 | $5,367,000 | 0.02% | Long | 2026-06-30 | |
| Optimum Small-Mid Cap Growth Fund | — | 95,119 | $5,105,037 | 0.54% | Long | 2026-06-30 | |
| VIP Health Care Portfolio | — | 95,000 | $5,098,650 | 0.44% | Long | 2026-06-30 | |
| Franklin Biotechnology Discovery Fund | — | 101,791 | $4,890,040 | 0.42% | Long | 2026-07-31 | |
| Fidelity Series Small Cap Core Fund | FSSLX | 98,200 | $4,717,528 | 0.30% | Long | 2026-07-31 | |
| Driehaus Micro Cap Growth Fund | DMCRX | 84,699 | $4,545,795 | 0.76% | Long | 2026-06-30 | |
| Mid Cap Growth Trust | — | 82,492 | $4,427,346 | 0.50% | Long | 2026-06-30 | |
| LVIP American Century Capital Appreciation Fund | — | 80,497 | $4,320,274 | 0.91% | Long | 2026-06-30 | |
| SA Wellington Capital Appreciation Portfolio | — | 74,187 | $3,981,616 | 0.15% | Long | 2026-06-30 |